D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$392M |
| 2 |
Starbucks
SBUX
|
+$370M |
| 3 |
Pfizer
PFE
|
+$338M |
| 4 |
PayPal
PYPL
|
+$320M |
| 5 |
Charles Schwab
SCHW
|
+$305M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$415M |
| 4 |
Citigroup
C
|
+$312M |
| 5 |
Booking.com
BKNG
|
+$289M |
Sector Composition
| 1 | Technology | 19.01% |
| 2 | Consumer Discretionary | 12.74% |
| 3 | Financials | 11.39% |
| 4 | Healthcare | 11.24% |
| 5 | Energy | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BWAC
1551
DELISTED
BETTER WORLD ACQUISITION CORP. Common Stock
BWAC
| $4.83M | ﹤0.01% |
470,678
-23,000
| -5% | -$236K |
|
1552
Aon
AON
$80.2B
| $4.83M | ﹤0.01% |
+14,840
| New | +$4.83M |
|
1553
Atossa Therapeutics
ATOS
$108M
| $4.83M | ﹤0.01% |
3,863,135
-284,674
| -7% | -$356K |
|
1554
East-West Bancorp
EWBC
$15.1B
| $4.82M | ﹤0.01% |
60,972
-43,282
| -42% | -$3.42M |
|
|
TWNI
1555
DELISTED
Tailwind International Acquisition Corp.
TWNI
| $4.81M | ﹤0.01% |
491,532
-581,766
| -54% | -$5.7M |
|
1556
GeoPark
GPRK
$325M
| $4.81M | ﹤0.01% |
321,687
-109,610
| -25% | -$1.64M |
|
1557
Cross Country Healthcare
CCRN
$411M
| $4.8M | ﹤0.01% |
221,507
+115,629
| +109% | +$2.51M |
|
|
PHYT
1558
DELISTED
Pyrophyte Acquisition Corp.
PHYT
| $4.8M | ﹤0.01% |
482,472
+415,579
| +621% | +$4.13M |
|
|
ATC
1559
DELISTED
Atotech Limited
ATC
| $4.8M | ﹤0.01% |
218,519
+113,314
| +108% | +$2.49M |
|
1560
Nutanix
NTNX
$21.2B
| $4.78M | ﹤0.01% |
178,252
+82,938
| +87% | +$2.22M |
|
|
VSAC
1561
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
| $4.78M | ﹤0.01% |
477,722
+325,000
| +213% | +$3.25M |
|
|
SPLK
1562
DELISTED
Splunk Inc
SPLK
| $4.77M | ﹤0.01% |
32,124
-29,497
| -48% | -$4.38M |
|
|
KRNL
1563
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
| $4.77M | ﹤0.01% |
486,315
-450,839
| -48% | -$4.42M |
|
1564
Children's Place
PLCE
$155M
| $4.77M | ﹤0.01% |
96,755
-12,506
| -11% | -$617K |
|
1565
Benchmark Electronics
BHE
$1.41B
| $4.76M | ﹤0.01% |
190,030
-19,261
| -9% | -$482K |
|
1566
Eagle Materials
EXP
$7.57B
| $4.76M | ﹤0.01% |
+37,046
| New | +$4.76M |
|
1567
Houlihan Lokey
HLI
$14.4B
| $4.75M | ﹤0.01% |
54,139
-65,635
| -55% | -$5.76M |
|
1568
Materials Select Sector SPDR Fund
XLB
$5.5B
| $4.75M | ﹤0.01% |
53,900
+3,400
| +7% | +$300K |
|
1569
FirstCash
FCFS
$6.49B
| $4.75M | ﹤0.01% |
67,495
-7,668
| -10% | -$539K |
|
1570
Equinox Gold
EQX
$8.29B
| $4.73M | ﹤0.01% |
572,513
+548,785
| +2,313% | +$4.54M |
|
|
LION
1571
DELISTED
Lionheart III Corp Class A Common Stock
LION
| $4.73M | ﹤0.01% |
476,042
| – | – |
|
|
DNAD
1572
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
| $4.73M | ﹤0.01% |
485,482
+42,699
| +10% | +$416K |
|
1573
Titan International
TWI
$552M
| $4.72M | ﹤0.01% |
320,737
-219,069
| -41% | -$3.23M |
|
1574
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $4.72M | ﹤0.01% |
365,787
+270,122
| +282% | +$3.49M |
|
1575
Bank of N.T. Butterfield & Son
NTB
$1.89B
| $4.72M | ﹤0.01% |
131,621
+30,606
| +30% | +$1.1M |
|